Anti-NMDA receptor encephalitis is a severe autoimmune brain disease in which the body’s immune system produces antibodies that attack NMDA receptors on the surface of neurons. First described in 2007, it has quickly become one of the most commonly recognized forms of autoimmune encephalitis, disproportionately affecting young women and children.1PubMed Central. Anti-NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review Because its earliest symptoms often look like a psychiatric crisis rather than a neurological emergency, the disease is frequently misdiagnosed, and understanding how it starts, what it looks like, and how it is treated can be genuinely life-saving.
What Causes It
The single most common identifiable trigger is an ovarian teratoma, a type of tumor that can contain bits of various body tissues, including brain tissue. When nerve-like cells inside a teratoma express NMDA receptors, the immune system may recognize those receptors as foreign and begin producing antibodies against them. Up to about 58% of adult women with the disease turn out to have an ovarian teratoma, and mature teratomas appear to carry a stronger association than other subtypes.2PubMed Central. The Association of Ovarian Teratoma and Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Updated Integrative Review In children and in men, teratomas are far less common, and the trigger is often never found.
Herpes simplex encephalitis is another recognized trigger. In a study following patients after herpes simplex brain infections, about a quarter developed autoimmune encephalitis during follow-up, and roughly two-thirds of those who did were found to have NMDA receptor antibodies.3The Lancet Neurology. Factors associated with clinical relapse after herpes simplex encephalitis and outcomes of autoimmune encephalitis triggered by herpes simplex virus The herpes virus itself damages neurons, and the resulting debris likely exposes NMDA receptors to the immune system in a way that kick-starts antibody production.4JAMA Neurology. Herpes Simplex Encephalitis as a Potential Cause of Anti–N-Methyl-d-Aspartate Receptor Antibody Encephalitis: Report of 2 Cases Clinicians now routinely test for NMDA receptor antibodies in patients who seem to worsen or relapse after recovering from herpes simplex encephalitis.
A substantial share of cases, especially in men and in young children, have no identifiable tumor or preceding infection. These are labeled idiopathic, meaning the immune trigger remains unknown.
How the Antibodies Damage the Brain
NMDA receptors sit on the surface of neurons and play a central role in learning, memory, and the regulation of behavior. The antibodies produced in this disease target a specific part of the receptor called the NR1 subunit.5PubMed Central. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies Rather than killing neurons outright, the antibodies latch onto receptors and cause them to cluster together and get pulled inside the cell, a process called internalization. The net effect is a dramatic drop in the number of working NMDA receptors on the neuron’s surface.6Nature Structural & Molecular Biology. Structural basis for antibody-mediated NMDA receptor clustering and endocytosis in autoimmune encephalitis
This loss of receptors is selective. Other types of receptors, synapses, and the neurons themselves remain intact, which is a key reason why recovery is possible. Laboratory studies have shown that once the antibodies are removed, NMDA receptor levels return to normal.7PubMed Central. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis The degree of receptor loss tracks with antibody levels in the spinal fluid: more antibodies, fewer working receptors, worse symptoms.8PubMed Central. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis This reversibility is both the good news and the reason aggressive treatment matters so much.
Symptoms and How They Unfold
The disease tends to move through recognizable phases, though the pace and severity vary from person to person. Early on, most patients develop psychiatric symptoms. In one series of over a hundred patients, roughly 57% presented initially with psychiatric problems, including mood changes, aggression, delusions, and hallucinations.9PubMed Central. Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis The remaining patients presented first with neurological symptoms like seizures, movement disorders, or speech problems.
As the disease progresses, nearly all patients develop psychiatric features. In the same series, 95% experienced at least one psychiatric symptom during their illness, with disorganized thinking (70%), manic behavior (62%), and psychotic symptoms (50%) being among the most common.9PubMed Central. Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis The early phase is what most often leads to misdiagnosis, because a young person suddenly hearing voices and behaving erratically looks, on the surface, like a first episode of psychosis or mania.
After the psychiatric phase, many patients enter a more clearly neurological stage. Seizures are common. Involuntary movements affecting the face and limbs appear, sometimes described as repetitive, rhythmic, and hard to control. Autonomic instability can cause wild swings in heart rate, blood pressure, and body temperature. Some patients develop dangerously suppressed breathing, requiring mechanical ventilation.10PubMed Central. Neurocritical care for Anti-NMDA receptor encephalitis Consciousness often decreases, and patients may become unresponsive for weeks to months. The overall trajectory has been described as psychiatric symptoms early, neurological deterioration in the middle, and then a prolonged recovery phase with lingering cognitive and behavioral difficulties.11PubMed Central. Anti-NMDA Receptor Encephalitis in Psychiatry
Why It Gets Mistaken for a Psychiatric Illness
The psychiatric presentation is so prominent that many patients are initially treated on psychiatric wards for presumed schizophrenia, bipolar disorder, or psychosis before anyone suspects an autoimmune cause. In a study of patients who experienced episodes appearing purely psychiatric, about three-quarters had delusions, nearly half had hallucinations, and more than half showed aggression.12JAMA Neurology. Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor Encephalitis In a prospective comparison of patients recovering from anti-NMDA receptor encephalitis with patients who had schizophrenia spectrum disorders, about 14% of the encephalitis patients would have met diagnostic criteria for schizophrenia if their spinal fluid antibodies had not been investigated.13The Lancet Neurology. Post-acute stage of anti-NMDAR encephalitis and comparison with schizophrenia spectrum disorders: a prospective observational cohort study
The overlap in symptoms has led to broader questions about how many patients sitting in psychiatric units with a diagnosis of psychosis actually have an undetected autoimmune condition. While the true proportion is likely small, the disease is serious enough that many clinicians now advocate for antibody testing in anyone presenting with rapid-onset psychosis, especially when accompanied by seizures, movement abnormalities, or rapid cognitive decline. Recognizing it early changes the treatment approach entirely, from antipsychotic medications to immunotherapy.14PubMed. Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications
How It Is Diagnosed
The definitive diagnostic test is detecting NMDA receptor antibodies in cerebrospinal fluid (CSF), obtained through a lumbar puncture. Testing the blood alone is not sufficient. In one analysis, every patient whose blood tested positive for the antibodies also tested positive in the CSF, but only about 63% of patients whose CSF was positive had detectable antibodies in their blood.15PubMed. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis In other words, blood testing misses a significant chunk of true cases, and a negative blood result cannot rule the disease out.
Patients with antibodies confirmed in CSF tend to present differently from those who test positive only in blood. CSF-positive patients are more likely to be female, to have a rapid onset of symptoms within three months, and to show abnormalities on EEG, MRI, and other CSF markers compared with patients who have antibodies only in serum.16PubMed Central. The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data MRI of the brain is often normal early in the disease, which can be misleading. An EEG may show a characteristic pattern of slow, disorganized electrical activity, and the CSF itself often shows mild inflammation with elevated white blood cells.
A newer research tool is measuring neurofilament light chain (NfL) levels in the blood, a marker of nerve fiber damage. Patients with anti-NMDA receptor encephalitis tend to have higher NfL levels than healthy individuals, and particularly elevated levels are seen in those who had a preceding herpes simplex infection or who show visible lesions on brain MRI.17PubMed Central. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDAR Receptor Encephalitis NfL is not yet used as a standalone diagnostic test, but it may help gauge the degree of brain injury and track disease activity over time.
Treatment
Treatment rests on two pillars: suppressing the immune attack and, when a teratoma is present, removing it surgically. The standard approach unfolds in tiers.
First-line immunotherapy typically includes high-dose intravenous corticosteroids, intravenous immunoglobulin (IVIG), or plasma exchange (sometimes called plasmapheresis), which physically filters antibodies out of the blood. A meta-analysis found that combinations of these first-line treatments improved outcomes: corticosteroids plus IVIG, or corticosteroids plus IVIG plus plasma exchange, were each associated with lower odds of a poor outcome compared with single agents used alone.18JAMA Neurology. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis International consensus guidelines for children recommend pulsed IV corticosteroids for all patients, with IVIG or plasma exchange added in severe cases, and prolonged first-line therapy continued for up to three to twelve months depending on severity.19PubMed. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis
When patients do not improve with first-line treatment, second-line agents come in. Rituximab, which depletes a type of immune cell involved in antibody production, and cyclophosphamide, a broader immunosuppressant, are the main options.20PubMed Central. Treatment Options in Refractory Autoimmune Encephalitis A systematic review and meta-analysis of rituximab as a second-line therapy for autoimmune encephalitis estimated a favorable prognosis rate of about 80%.21Heliyon. Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis For severely refractory cases that fail standard escalation, bortezomib, a drug that targets antibody-producing plasma cells, has shown promise in small case series, with improvement or remission in four of five treated patients in one report.22PubMed. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
The Role of Tumor Removal
When an ovarian teratoma is found, surgical removal is considered essential. The tumor is the source of the immune trigger, and leaving it in place means the immune system keeps encountering the provocation. Around half of patients with teratoma-associated disease show rapid improvement after surgery combined with immunotherapy.23PubMed Central. Successful Treatment of Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Bilateral Ovarian Teratomas Through Three Surgeries Without Loss of Fertility The remaining patients improve more slowly and face higher risk for complications.
Timing matters. Patients who have the teratoma removed within the first month of symptom onset tend to have higher rates of complete recovery compared with those whose surgery is delayed.24International Journal of Women’s Health. Early Ovarian Teratoma Resection Improves Outcomes in Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Dual-Case Series This is one reason why imaging of the pelvis is part of the early workup for any woman or girl diagnosed with the disease. Fertility-sparing surgery, removing just the tumor while preserving the ovary, is often possible and has been reported even in patients with bilateral teratomas.
Recovery and Relapse
The majority of patients improve, though the road is often long. In a large observational cohort, about 81% of patients had a good functional outcome at 24 months, and recovery continued to improve for up to 18 months after symptom onset.25The Lancet Neurology. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study A cohort study in western China reported that roughly 85% of patients showed improvement within the first four weeks of immunotherapy, and by 24 months about 86% had mild or no residual symptoms.26PubMed Central. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China
Relapses happen, though they tend to be less severe than the first episode. In the large observational cohort, about 12% of patients relapsed within two years, and roughly two-thirds of those relapses were milder than the initial attack.25The Lancet Neurology. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study A more recent study of over 500 patients found a 9% relapse rate, with most relapses presenting as a single core symptom rather than the full multi-stage illness, and with a median time to relapse of about two years.27PubMed Central. Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features Most patients who relapse do so only once.
Differences Between Children and Adults
The disease affects a wide age range, but how it presents and how it responds to treatment differ by age. The condition is overwhelmingly female overall, affecting women and girls in about 81% of cases, but the sex ratio shifts in younger children: in one pediatric series, only a third of patients under age 12 were female, while all those over 12 were.28PubMed Central. Pediatric Anti-NMDAR encephalitis-Clinical analysis and novel findings in a series of 20 patients The younger the child, the more likely the initial presentation is neurological (seizures, movement disorders) rather than psychiatric, partly because behavioral changes in very young children are harder to characterize as psychiatric.
Adults tend to have a more complicated hospital course. They are more likely to develop status epilepticus, central hypoventilation requiring a ventilator, and pneumonia. Children, on the other hand, are more likely to present with prominent movement disorders. Recovery tends to be faster in children, especially in the first six months, and risk factors for a worse outcome in adults include status epilepticus and changes in consciousness.29PubMed. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis
Life After the ICU
Even after the acute phase resolves, many patients and their families face a grueling recovery. Cognitive problems, including difficulty with memory, attention, and executive function, can linger for months or years. Personality changes sometimes persist. Fatigue is common and can be disabling on its own. Many patients who were previously independent find themselves unable to work, attend school, or drive for extended periods.
Caregivers carry a heavy burden. In a survey of 76 caregivers of people with anti-NMDA receptor encephalitis, the average caregiver burden score fell in the moderate-to-severe range. Nearly three-quarters of caregivers reported that when the patient left the hospital, they did not receive a readable, understandable written plan for how their healthcare needs would be met. Over 60% said they were not confident they knew how to manage the patient’s health at discharge.30PubMed. Assessment of care transitions and caregiver burden in anti-NMDA receptor encephalitis Higher caregiver burden was associated with worse discharge planning and with the patient not being able to return to driving. The disease may be treatable, but the infrastructure supporting patients and families after the crisis often falls short.
Historical Cases That May Have Been Anti-NMDA Receptor Encephalitis
Because the disease was only identified in 2007, there has been considerable retrospective speculation about historical cases. Some researchers have suggested that cases of so-called demonic possession throughout history could represent unrecognized anti-NMDA receptor encephalitis, given the hallucinations, altered behavior, seizures, and unusual movements the disease produces. The condition has also been proposed as an explanation for some historical cases of encephalitis lethargica, malignant catatonia, and other previously unexplained neuropsychiatric syndromes.31Annals of Neurology. In Search of Lost Time From Demonic Possession to Anti-N-Methyl-D-Aspartate Receptor Encephalitis These retrospective diagnoses are inherently speculative, since antibody testing could not have been performed, but they underscore how dramatic and bewildering this disease looks from the outside: a previously healthy young person suddenly becomes psychotic, develops seizures, and slips into unresponsiveness. Before 2007, there was no framework to explain it.